L. Jeworowski

发表

A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model

M. Endres, I. Wilson, A. Gruber, 2020, Cell.

A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model

M. Endres, I. Wilson, A. Gruber, 2020, bioRxiv.

A Sars-Cov-2 Neutralizing Antibody Protects from Lung Pathology in a Covid-19 Hamster Model

I. Wilson, A. Gruber, M. Höltje, 2020 .

Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory

D. Jäger, C. Buchholz, C. E. Engeland, 2021, Molecular therapy oncolytics.

Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists

D. Jäger, C. E. Engeland, G. Ungerechts, 2019, Viruses.

Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations

V. Corman, C. Drosten, K. Ruprecht, 2022, medRxiv.

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases

G. Burmester, V. Corman, C. Drosten, 2022, Annals of the Rheumatic Diseases.

SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression

S. Ciesek, A. Hocke, T. Wolff, 2022, PLoS biology.

Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line

S. Ciesek, A. Hocke, T. Wolff, 2021, bioRxiv.

Ecological drivers of Hepacivirus infection in a neotropical rodent inhabiting landscapes with various degrees of human environmental change

V. Corman, C. Drosten, S. Sommer, 2018, Oecologia.

Host Biology and Anthropogenic Factors Affect Hepadnavirus Infection in a Neotropical Bat

M. Tschapka, J. Drexler, D. Glebe, 2018, EcoHealth.

Ecological drivers of Hepacivirus infection in a neotropical rodent inhabiting landscapes with various degrees of human environmental change

V. Corman, C. Drosten, S. Sommer, 2018, Oecologia.

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

I. Wilson, M. Hoelscher, D. Schmitz, 2021, bioRxiv.

Mapping SARS-CoV-2 antigenic relationships and serological responses

X. Daniell, R. Webby, M. Stockwell, 2022, bioRxiv.

Impaired B Cell Recall Memory and Reduced Antibody Avidity but Robust T Cell Response in CVID Patients After COVID-19 Vaccination

C. Scheibenbogen, V. Corman, C. Drosten, 2023, Journal of Clinical Immunology.

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

G. Burmester, V. Corman, J. Klotsche, 2022, RMD Open.

Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants

V. Corman, C. Drosten, D. Niemeyer, 2023, bioRxiv.

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron

K. Eschke, V. Corman, H. Prüss, 2023, iScience.